Physician profile
Hatem Alassy
NPI 1669461802
$6,965.09
in general payments reported to CMS, 2019-2025
8 companies · $3,720 in 2025
The $3,720 reported for 2025 was more than what 95% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,405 · 2023: $34.30 · 2024: $1,806 · 2025: $3,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,380 · Food and Beverage: $1,846 · Education: $215 · Gift: $100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,380.41 |
| Food and Beverage | $1,845.81 |
| Education | $214.95 |
| Gift | $100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,704.73 | 2023-2025 | |
| Zimvie INC. | $1,590.59 | 2024 | |
| Zimmer Biomet Holdings, INC. | $1,306.07 | 2019 | |
| Hu-Friedy Mfg. Co., LLC | $214.95 | 2024 | |
| Dentsply Ih INC. | $83.58 | 2019 | |
| Geistlich Pharma, North America, INC. | $35.33 | 2025 | Biomaterials |
| Dentsply Sirona Orthodontics INC | $15.77 | 2019 | |
| Dentsply Sirona INC | $14.07 | 2025 | Cercon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hatem Alassy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.